Thursday, April 9, 2020

Testing COVID Meds On Prisoners

While many state and federal prisons still resist the release of low-risk incarcerated people,including elderly and seriously ill, the Bureau of Prison just purchased $60,000 worth of hydroxychloroquine, the coronavirus treatment promoted by President Trump for an off label use.  The drug has not been approved by the FDA for treating the virus nor have any clinical trials been done. A limited amount has been authorized for treating coronavirus patients.

Yahoo News reported that "The nation's top infectious-disease expert, Dr. Anthony Fauci, a member of the White House's coronavirus task force, has repeatedly warned that there is not enough evidence that the drug is effective, and that existing studies only provide "anecdotal evidence" and have been too small to prove the drug works."  The BOP gives the predictable reasons for the purchase. The BOP indicated that the drugs are intended to treat COVID-19 patients, although no word was given as to whether correctional officers will receive the treatment.  8 incarcerated individuals have died in federal prisons with at least 185 having tested positive.

The President has been promoting the drug for treatment and prophylactic purposes, without any clinical proof of effectiveness.  By all appearances the incarcerated will be the experiments for an unauthorized trial.  No reliable data is likely to come from the "experiment", just as no reliable data came from many other times the incarcerated's human rights have been violated in this country when their unwilling, and often unknowing, bodies were used for medical and psychological experiments. The President is determined to be a hero of the crisis and illegal and unethical use of the unapproved medication is how he will claim that status.  

Others caught in federal systems are likely to be subjected to the same experimentation as it is reported that the Veterans Administration purchased over $200,000 worth of the drug in the last couple of days.  Chilling.

| Permalink


Post a comment